SEPAC

Screening and early detection to prevent anal cancer; development of a biomarker screening tool.

Project Summary

SEPAC is an observational anal pre-cancer screening study.

As a part of the SEPAC study, 5 HIV clinics across London provide an opportunity for anyone living with HIV, aged 40 years or older and MSM / transgender women (male at birth) to be screened for anal pre-cancer. All participants will undergo high resolution anoscopy examination and have samples taken for biomarker analyses. To learn more about the SEPAC study, please contact Research Nurse Deirdre Sally (d.sally@nhs.net).

The study aims to develop and evaluate a primary screening tool for anal pre-cancer that would allow the identification and treatment of early disease, to help detect anal pre-cancer earlier and improve anal cancer outcomes.